In part one of this series, we explored whether a male-dominated AI ecosystem risks widening the gender gap. The ...

Results from single-arm clinical trials can be contextualized by comparing against external controls (ECs) derived from real-world data (RWD). However, lack of randomization and differences in ...

Digital patient profiles and real-world data enhance oncology trial design, patient recruitment, and reduce trial failure risks. Phesi's platform aligns trial designs with real-world data, minimizing ...

Artificial intelligence (AI) is rapidly reshaping how healthcare advice is delivered. From symptom checkers and diagnostic tools to risk models and care-navigation platforms, AI is becoming a first ...

Real-world evidence (RWE) has become a crucial driver of the pharmaceutical and biotechnology industries in recent years. In fact, RWE is now included in 70 percent of new drug and biologic regulatory ...

AI’s progress has hit a critical constraint: access to real-world data. While public datasets and web scraping powered AI’s early breakthroughs, today’s models demand proprietary data from hospitals, ...